← Back
$HALO All transactions

HALOZYME THERAPEUTICS, INC.

▼ SELL 10b5-1 Plan

$ Value

$25K

Shares

314

Price

$79

Filed

Sep 23

Insider

Name

LaBrosse Nicole

Title

SVP, CHIEF FINANCIAL OFFICER

CIK

0001910662

Roles

Officer

Transaction Details

Transaction Date

2025-09-22

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

22,079

Footnotes

The sales reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025. | Represents a weighted average sales price per share. These shares were sold at prices ranging from $77.34 to $78.32. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | Represents a weighted average sales price per share. These shares were sold at prices ranging from $78.37 to $79.18. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Filing Info

Accession No.

0001910662-25-000003

Form Type

4

Issuer CIK

0001159036

LaBrosse Nicole's History

Date Ticker Type Value
2025-09-22 HALO $149K
2025-09-22 HALO $25K
2025-09-10 HALO M $136K
2025-09-10 HALO M $14K
2025-09-10 HALO $509K
2025-09-10 HALO $1.0M
2025-09-10 HALO M $0
2025-09-10 HALO M $0

Other Insiders at HALO (90d)

Insider Bought Sold Last
RAMSAY DAVID A
Interim CFO
2026-04-01
Torley Helen
PRESIDENT AND CEO
$3.2M 2026-04-06